Mallinckrodt PLC (NYSE: MNK) was reiterated as Sell and its price target was cut to $1 from $2 at Citigroup. Shares closed down 5% at $1.54 on Wednesday and were indicated down another 5.8% at $1.45 on Thursday.
Moderna Inc. (NASDAQ: MRNA) was reiterated as Market Perform and its target price was trimmed to $60 from $65 (versus a $75.80 close) at SVB Leerink.
Novavax Inc. (NASDAQ: NVAX) closed up just over 10% at $173.49 on Wednesday after positive COVID-19 study data. H.C. Wainwright reiterated its Buy rating and raised its target to $190 from $132.00.
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) was reiterated as Neutral and its price target was raised to $635 from $585 (versus a $624.52 close) at Citigroup.
Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) was reiterated as Buy and its price target was raised to $8 from $7 (versus a $2.52 close) at Citigroup. It had a $7.33 consensus target price ahead of the call, but its market cap is just $425 million.
Roku Inc. (NASDAQ: ROKU) was reiterated as Buy at Benchmark and its target was raised to $185 from $180. Needham reiterated its Buy rating and raised its price target to $190 from $150, and Rosenblatt reiterated it as Buy and raised its target to $195 from $190.
Square Inc. (NYSE: SQ) was raised to Neutral from Sell with a $140 target price at Compass Point. Rosenblatt reiterated it as Buy and raised its target to $181 from $136, and KeyBanc reiterated its Overweight rating and raised its price target from $140 to $165.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) was raised to Equal Weight from Underweight with a $13 price target at Barclays.
Wayfair Inc. (NYSE: W) was raised to Equal Weight from Underweight with a $320 price target (versus a $300.94 close) at Barclays.
Western Digital Corp. (NASDAQ: WDC) was last seen down 12% at $39.10 on Thursday morning after earnings and guidance. Benchmark maintained it as Buy but cut its target price to $52 from $60.
Williams Companies Inc. (NYSE: WMB) was reiterated as Buy and its price target was raised to $26 from $24 (versus a $21.29 close) at Citigroup.
Zynga Inc. (NASDAQ: ZNGA) was reiterated as Overweight and its price target was raised to $12 from $11 (versus a $10.07 close) at KeyBanc Capital markets.
With more calls for $3,000 gold and much higher silver prices, some of the gold-mining stocks have huge upside if this ride goes into blastoff mode.
Wednesday’s top analyst upgrades and downgrades included Activision Blizzard, AON, Enphase Energy, Monster Beverage, New Relic, Novavax, Paycom, Walt Disney and Wynn Resorts.